PD Dr. Alexander Hein


Medizinische Fakultät

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 10 Go to next page Go to last page

Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Fasching, P., Hartkopf, A.D., Gaß, P., Häberle, L., Akpolat-Basci, L., Hein, A.,... Kolberg, H.-C. (2019). Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis. Breast Cancer Research and Treatment, 173(2), 319-328. https://dx.doi.org/10.1007/s10549-018-5008-3
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-17-3864
Escala-Garcia, M., Guo, Q., Doerk, T., Canisius, S., Keeman, R., Dennis, J.,... Schmidt, M.K. (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120(6), 647-657. https://dx.doi.org/10.1038/s41416-019-0393-x
Wallwiener, M., Nabieva, N., Feisst, M., Fehm, T., De Waal, J., Rezai, M.,... Fasching, P. (2019). Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5806-y
Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A.,... Easton, D.F. (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics, 104(1), 21-34. https://dx.doi.org/10.1016/j.ajhg.2018.11.002
Nabieva, N., Häberle, L., Brucker, S.Y., Janni, W., Volz, B., Löhberg, C.,... Fasching, P. (2019). Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients. International Journal of Cancer. https://dx.doi.org/10.1002/ijc.32294
Preu, C., Heindl, F., Hein, A., Koch, M., Ga, P., Beckmann, M.,... Emons, J. (2019). Primäre Prävention - Mamma- und Genitalkarzinome. TumorDiagnostik & Therapie, 40(6), 364-373. https://dx.doi.org/10.1055/a-0965-0804
Fasching, P., Gaß, P., Häberle, L., Volz, B., Hein, A., Hack, C.,... Erber, R. (2019). Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment. https://dx.doi.org/10.1007/s10549-019-05198-9
Häberle, L., Erber, R., Gaß, P., Hein, A., Jud, S., Langemann, H.,... Fasching, P. (2018). A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.

Zuletzt aktualisiert 2017-15-10 um 02:01